Literature DB >> 2427301

[Isovolemic hemodilution in stage-IIb peripheral arterial occlusive diseases. Prospective randomized double-blind comparison of middle-molecule hydroxyethyl starch and electrolyte solution].

H Kiesewetter, F Jung, J Blume, M Gerhards.   

Abstract

Blood-letting to a haematocrit of 0.40 to 0.42 was performed over a period of six weeks on 30 randomized patients with peripheral vascular disease (intermittent claudication), stage IIb (after Fontaine), in addition to standardized gymnastics and physical exercise (walking). Subsequently, 15 randomly selected patients received after each blood-letting middle-molecular hydroxyethyl starch solution, another 15 randomized patients received isotonic sodium chloride solution, both groups under a double-blind protocol, gymnastics and walking exercise being continued. At the beginning of the study both groups were comparable with respect to clinical and vascular parameters and results of laboratory tests. Those of the former group had a significantly greater increase in pain-free walking distance than the latter. Blood pressure levels remained unchanged in the former, but significantly rose in the latter. Peak flow during reactive hyperaemia increased significantly in both legs in the first group, remaining unchanged in the second. An increase in spontaneous platelet aggregation occurred only in the second group; alpha 2-macroglobulin concentration rose only in patients of the first group, while fibrinogen decreased significantly in both.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427301     DOI: 10.1055/s-2008-1068625

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

1.  Clinical effects of intravenous iloprost in patients with intermittent claudication.

Authors:  U Müller-Bühl; C Diehm; T Krais; R Zimmermann; H Mörl; H H Eckstein
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  [Bag plasmapheresis in patients with stage IIb peripheral arterial occlusive disease].

Authors:  H Kiesewetter; J Blume; F Jung; M Gerhards; S Spitzer; G Leipnitz; E Wenzel
Journal:  Klin Wochenschr       Date:  1988-04-01

3.  Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study.

Authors:  S Wolf; O Arend; B Bertram; A Remky; K Schulte; K J Wald; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117

4.  [Hemodilution in patients with stage IIb peripheral arterial occlusive disease: prospective randomized double-blind comparison of middle-molecular weight hydroxyethyl starch and low-molecular weight dextran solution].

Authors:  H Kiesewetter; F Jung; J Blume; M Gerhards
Journal:  Klin Wochenschr       Date:  1987-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.